4 hr New York State Healthcare Provider Education: Medical Use of Marijuana

New York State Department of Health
Primary Course Director: Jeffrey Hergenrather, MD
Co-Director: Michelle Sexton, ND


You Will Learn About

  • The New York State Medical Marijuana Program
  • The Endocannabinoid System
  • Pharmacology of Cannabis
  • Delivery and Dosage of Cannabis Medicine
  • Cannabis in Movement and Digestive Disorders, Neurodegenerative Diseases, Cancer, Pain, Immune Deficiency Syndromes

Developed by the Society of Cannabis Clinicians (SCC) and approved by the New York State Department of Health (NYSDOH), this online curriculum is designed to educate practitioners who wish to register with the Department to certify patients for the medical use of marijuana under New York State’s Compassionate Care Act as well as pharmacists who will be working in dispensing facilities of registered organizations.

Purchase grants one learner one year’s access to lessons and quizzes (access expires 365 days from date of course activation).

NOTE: Bulk pricing is available! Call 844.490.2569 or email info@tmciglobal.org.

Registration Instructions from the New York State Department of Health:

Physicians, Nurse Practitioners and Physician Assistants seeking to register with the New York State Department of Health (NYSDOH) to certify patients for medical marijuana must complete a NYSDOH approved Medical Use of Marijuana course. Pharmacists working in dispensing facilities must successfully complete a NYSDOH approved Medical Use of Marijuana course before they may counsel, or supervise another employee who may counsel certified patients and designated caregivers on the use, administration, and risks associated with approved medical marijuana products.

Instructions for practitioners looking to register with the NYSDOH:

Following successful completion of the New York State Department of Health (NYSDOH)-approved course, and upon full compliance with the other requirements set forth in 10 NYCRR §1004.1(a), practitioners who wish to register with NYSDOH to certify patients for medical marijuana must follow the below steps:

Log into the Health Commerce System,
Select “All Applications” from the My Content dropdown menu,
Click the “M” tab, find the Medical Marijuana Data Management System (MMDMS) application in the list, and click the green and white “+” icon in the “Add/Remove” column to add the MMDMS application.
After selecting the MMDMS application, practitioners will be prompted to enter information required to complete the registration process.
Please retain a copy of your course completion certificate from the approved course provider for your records.

Any questions about this process and/or any issues with registering should be directed to mmp@health.ny.gov.

Lesson Plan

The Endocannabinoid System

  • The basic function of the endocannabinoid system in various tissues, organs, and body systems.
  • The physiologic effect of cannabis on body systems and the side effects of cannabis that patients may experience.

Pharmacology of Cannabis

  • The pharmacokinetics of cannabis absorption, distribution, metabolism and elimination in order to facilitate patient treatment.

Cannabis Use Disorders and Precautions; Delivery and Dosage of Cannabis Medicine

  • The differences in the absorption and metabolism rates with different methods of cannabis administration in patient treatment.
  • Cannabis dependence, addiction, tolerance, and withdrawal.
  • Six common delivery systems and dosage considerations for medical cannabis in order to facilitate patient treatment.

Cannabis in Movement Disorders, Neuropathies, Cancer, Pain, Digestive Disorders and Immune Deficiency Syndromes

  • The utility of cannabis in symptom management in cancer patients.
  • The physiological mechanisms by which cannabinoids may be therapeutic for neurodegenerative disorders.
  • The use of cannabis for the following severe, debilitating or life-threatening conditions: cancer, HIV infection or AIDS, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, multiple sclerosis, spinal cord injury with spasticity, epilepsy, inflammatory bowel disease, neuropathy, Huntington’s disease and chronic pain. The severe, debilitating or life-threatening condition must be accompanied by cachexia or wasting syndrome, severe or chronic pain, severe nausea, seizures, or severe or persistent muscle spasms.


Primary Course Director: 
Jeffrey Hergenrather, MD






Michelle Sexton, ND

Contributing Faculty Members:
  • Dustin Sulak, DO
  • Laura Borgelt, PharmD, FCCP, BCPS
  • Deborah Malka, MD, PhD
  • Mary Lynn Mathre, RN, MSN, CARN
  • John McPartland, DO
  • Donald Abrams, MD
  • Michelle Sexton, ND
  • Jeffrey Hergenrather, MD
  • Stacey Marie Kerr, MD
  • Arnold Leff, MD
  • Sydney J. Kurn, MD